Search

Displaying results 2371 - 2380 of 10000 in total
  1. Indication

    Non-Invasive Bladder Urothelial Carcinoma

    go.drugbank.com/conditions/DBCOND0134053
    Drugs: BCG vaccine
    Synonyms: Non-Invasive Bladder Urothelial Carcinoma
  2. Indication

    Non-Small Cell Lung Carcinoma

    go.drugbank.com/conditions/DBCOND0030527
    Drugs: Atezolizumab · Epirubicin · Osimertinib
    Synonyms: Carcinoma Non-small Cell Lung, Non-Small Cell Lung Carcinoma
  3. Indication

    Non-obstructive postpartum urinary retention

    go.drugbank.com/conditions/DBCOND0138338
    Drugs: Bethanechol
    Synonyms: Non-obstructive postpartum urinary retention
  4. Indication

    Non-q wave myocardial infarction

    go.drugbank.com/conditions/DBCOND0023450
    Drugs: Nadroparin
    Synonyms: Non-Q wave MI, Attack heart (NOS)
  5. Drug

    GI-5005

    go.drugbank.com/drugs/DB05942
    Investigational

    GI-5005 is GlobeImmune's lead infectious disease product from its proprietary Tarmogen active immunotherapy platform for the treatment of chronic hepatitis C infection. GI-5005 is whole, heat-killed recombinant yeast genetically modified...

  6. Drug

    Phosphorus

    go.drugbank.com/drugs/DB14151
    Approved

    Mixtures: Complete One A Day Tab, Nature"s Way Kids A+ Calcium + Vitamin D3 softgel capsules
  7. Drug

    Gemeprost

    go.drugbank.com/drugs/DB08964
    ApprovedWithdrawn

    It is not FDA-approved but available in Japan marketed as Preglandin.

  8. Drug

    Edotreotide gallium Ga-68

    go.drugbank.com/drugs/DB15494
    Approved

    [A185852] Dotatate gallium Ga-68 has lower tumor uptake but this data is highly variable between patients.[A185852] Edotreotide gallium Ga-68 was granted FDA approval on 21 August 2019.[L8597] … [L8603] Edotreotide gallium Ga-68 is indicated for localizing somatostatin receptor positive neuroendocrine tumors by positron emission tomography.

  9. Drug

    Remibrutinib

    go.drugbank.com/drugs/DB16852
    ApprovedInvestigational

    Remibrutinib is a selective Bruton's tyrosine kinase inhibitor. The FDA approved remibrutinib on September 30, 2025 as the only oral, targeted treatment for chronic spontaneous urticaria. Bruton's tyrosine kinase plays a role in B cell r...

  10. Drug

    Doxercalciferol

    go.drugbank.com/drugs/DB06410
    ApprovedInvestigational

    Doxercalciferol is marketed under the brand name Hectoral by Genzyme Corporation, and is manufactured by Catalent Pharma Solutions, Inc.

    Synonyms: (1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol